NEW! Small hospital solution 🏥See Now →
ASHP PCAC + DoseMeRx
The most efficient and cost-effective means to comply with the revised consensus guidelines for monitoring vancomycin.
We know at small hospitals you have special challenges in implementing the 2020 vancomycin dosing guidelines. The updated vancomycin dosing guidelines recommend hospitals transition from trough-only to AUC-based monitoring.
For small and rural hospitals, this can be a daunting task. Together with the American Society of Health-System Pharmacists (ASHP), we created a streamlined solution to make the transition easier and cost-effective.
The good news is, you don’t even need to be an ASHP member to access it. PCAC + DoseMeRx is a unique solution that includes ASHP’s competency management subscription PCAC, plus access to DoseMeRx, our world-leading Bayesian dosing platform.
Full access to ASHP’s completely updated and expanded competency management subscription- Pharmacy Competency Assessment Center (PCAC) for Institutions.
Unlimited use of the DoseMeRx web-based solution for up to 10 users at a single site.
Making pharmacists’ lives easier is a 24/7 job. That’s why our friendly customer support team of problem-solvers is available round-the-clock. You can always speak to a real, qualified person, day or night.
Vancomycin bundle, including the Standard Adult, Pediatric, and Enhanced Obese Adult drug models.
Our web-based platform can be accessed on any internet-enabled device and is mobile-friendly.
PCAC + DoseMeRx is available to any hospital with 100 beds or less. Whether you have a question about features, pricing, need a demo, or anything else, our partners at ASHP are ready to answer all your questions.
“The new recommendation to use AUC is an important and significant shift in vancomycin dosing and monitoring as we seek to advance better patient outcomes. ASHP is pleased to be able to support pharmacists in small and rural hospitals, particularly as they face limited resources and budgets, with a scientifically rigorous Bayesian dosing platform to more efficiently calculate vancomycin doses.”
Daniel J. Cobaugh
Pharm.D. FAACT, DABAT, vice president of publishing at ASHP and editor-in-chief of AJHP.
We combine smart technology with science leveraging clinically-validated PK/PD models, patient characteristics, drug concentrations, and genotype to accurately individualize a dose in seconds.